Patholase

The New York College of Podiatric Medicine has received a donation from PathoLase, Inc., of the company’s patented new PinPointe™ FootLaser™ for the treatment of onychomycosis, and will be teaching the College’s students to use the new technology in conjunction with a clinical research study to be conducted at the College’s clinical affiliate, Foot Clinics of New York.

Dr. Michael Trepal, NYCPM Vice President for Academic Affairs and Dean, said, “We are very pleased to have the PinPointe FootLaser at the College to educate our students and faculty on an alternative method for treating the difficult and debilitating condition known as onychomycosis. We are also pleased that, as part of the clinical education we offer, and as part of the upcoming clinical trial, we will soon be able to offer patients at our clinical affiliate, Foot Clinics of New York, this alternative, non-invasive approach for patients suffering from toenail fungus.” Foot Clinics of New York expects that it will be able to start of